Beta Bionics (Nasdaq:BBNX) announced that it agreed to integrate its iLet bionic pancreas with a future dual sensor from ...

Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

Glucose toxicity, on the other hand, ... Cite this: Glucose Toxicity in Beta-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection - Medscape - Mar 01, 2003.

Beta Bionics, Inc. has announced plans to integrate its iLet Bionic Pancreas automated insulin delivery system with Abbott’s upcoming dual glucose-ketone sensor in the United States.

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor Provided by GlobeNewswire Jun 19, 2025, 11:00:00 AM ...

A new international study published in The American Journal of Clinical Nutrition shows that simply replacing regular bread ...

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet ...

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ...

Multiple developers of connected diabetes hardware have announced plans this week to link their insulin pumps with continuous ...